Breast Cancer
Commentary
Point/Counterpoint: Should breast MRI be used routinely in the preoperative evaluation of breast cancer?
News
FDA reports shortage of doxorubicin for injection, initiates importation
News
In-person, telephone genetic counseling yield similar outcomes
Key clinical point: Telephone genetic counseling was noninferior to in-person counseling for women at increased risk of hereditary breast and/or...
News
Immune agonist, checkpoint inhibitor combo shows good tolerability
Combining two immunotherapies, one inhibiting immune suppression and the other stimulating immune activation, is well tolerated and shows activity...
Conference Coverage
Adjuvant AI therapy for breast cancer: 10 years is superior to 5 years
Extending adjuvant aromatase inhibitor (AI) therapy from 5 years to 10 years further reduces the risk of recurrence and new breast cancer in...
Video
VIDEO: Dr. William A. Gradishar and Dr. Hope S. Rugo discuss #ASCO16
News
MyPathway: Targeted therapies show promise in nonindicated tumors
Agents that target the HER2, BRAF, Hedgehog, or EGFR pathways show promise in nonindicated tumor types that harbor these molecular alterations,...
Conference Coverage
Liquid biopsies prove useful alternative to tissue biopsies
Liquid biopsy, the testing of the blood for circulating tumor DNA (ctDNA), identified cancer mutations useful as biomarkers – many associated with...
Video
VIDEO: Direct-to-patient study empowers patients, accelerates research
Video
VIDEO: Doctors should be challenged to extend AIs
Conference Coverage
Ethnic groups differ in BRCA risk management
Black, Hispanic, and white women differ in BRCA risk management.